Stockreport

Final Study Completed for Cingulate's Lead Asset CTx-1301 [Yahoo! Finance]

Cingulate Inc.  (CING) 
PDF Submission of New Drug Application Targeted for Mid 2025 KANSAS CITY, Kan., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical comp [Read more]